Skip to content

STOKSTOKE THERAPEUTICS INC

CUSIP 86150R107 · common stock

2 tracked investors held STOKE THERAPEUTICS INC (STOK) at the end of Q3 2026, worth $36.1M in total. The largest holder was Julian Baker, with 0.2% of its portfolio. RA Capital Management opened a new position this quarter.

Holders · Q3 2026
2
New holders
1
Value held
$36.1M
Quarter-end price (est.)
$26.00

Investors holding STOK · Q3 2026

InvestorWeightSharesValueChange
Julian Baker
Baker Bros. Advisors LP
0.16%1,313,999$34.2MREDUCE-60.6%
RA Capital Management
RA Capital Management, L.P.
0.02%73,607$1.9MNEW

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026210$36.1M$26.00
Q2 2026100$109.2M$32.72
Q1 2026100$108.6M$32.56
Q4 2025100$105.9M$31.74